Skip to main content

Biopharma Startups

Updated July 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 854 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
854
Total Funding
$859.9M
Avg Funding
$34.4M
Global Reach
6
countries

Top Cities for Biopharma

Los Angeles
Indianapolis
South San Francisco
Madison
Waltham
Cambridge

Recently Funded Companies

Export
Los Angeles, United States

ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.

$300.0M raised
Sep 2022

Founder Contacts

30,000+ verified contacts

Indianapolis, United States

Point Biopharma focused on the development and commercialization of radioligand therapies for the treatment of cancer.

$125.0M raised
Sep 2022

Founder Contacts

30,000+ verified contacts

South San Francisco, United States

Novome Biotechnologies is a biotechnology company focused on engineering defined activities into the human.

$43.5M raised
Sep 2022

Founder Contacts

30,000+ verified contacts

Madison, United States

BrainXell provides a range of high-purity, iPSC-derived human neurons for research and development with a focus on drug discovery.

$13.2M raised
Sep 2021

Founder Contacts

30,000+ verified contacts

Waltham, United States

Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.

$150.0M raised
Sep 2025

Founder Contacts

30,000+ verified contacts

Cambridge, United Kingdom

PhoreMost is a new-model drug discovery company based in Cambridge, UK.

$12.0M raised
Sep 2024

Founder Contacts

30,000+ verified contacts

Los Angeles, United States

Pythia Labs is an LA-based start-up that crafts computational solutions to facilitate the discovery and design of biomolecular therapeutics.

$10.0M raised
Sep 2021

Founder Contacts

30,000+ verified contacts

Arlington, United States

Revere Pharmaceuticals develops a drug discovery and development platform targeting Rac1 and its genomic variants.

$1.1M raised
Sep 2021

Founder Contacts

30,000+ verified contacts

Huntsville, United States

KALM Therapeutics provides non-steroidical treatment for eczema and psoriasis.

$590K raised
Aug 2024

Founder Contacts

30,000+ verified contacts

Vienna, United States

Enhanced Fusion Technologies is a biotechnology company.

$480K raised
Aug 2025

Founder Contacts

30,000+ verified contacts

San Diego, United States

Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.

$25.0M raised
Aug 2023

Founder Contacts

30,000+ verified contacts

Cambridge, United States

Artax Biopharma is a biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.

$8.0M raised
Aug 2024

Founder Contacts

30,000+ verified contacts

Singapore, Singapore

Cellivate Technologies develops engineered cell culture surfaces, consumables, and services for adherent cell growth and scale-up.

$1.0M raised
Aug 2024

Founder Contacts

30,000+ verified contacts

Singapore, Singapore

Startup, with proprietary platform technologies and products that enable cellular meat companies to accelerate the growth of cells

$1.0M raised
Aug 2024

Founder Contacts

30,000+ verified contacts

Barcelona, Spain

NIMBLE Diagnostics offers a range of paternity, family relationship, and ancestry DNA testing services.

Aug 2024

Founder Contacts

30,000+ verified contacts

Tarrytown, United States

Visiox biopharmaceutical company focused on the development and commercialization to address highly prevalent diseases.

$7.0M raised
Aug 2022

Founder Contacts

30,000+ verified contacts

Newton, United States

A Best-in-Class Cell-Health Engineering Platform. Pioneering a New Performance Layer for Biologic Manufacturing and Stability

$1.2M raised
Aug 2025

Founder Contacts

30,000+ verified contacts

Ann Arbor, United States

Evoq Therapeutics is a cancer immunotherapy company that provides disease-specific immune modulators.

$2.0M raised
Aug 2024

Founder Contacts

30,000+ verified contacts

Marseille, France

ImCheck Therapeutics designs and develops immunotherapeutic antibodies for the treatment of cancer and autoimmune disease.

$22.4M raised
Aug 2024

Founder Contacts

30,000+ verified contacts

Bristol, United Kingdom

EnsiliTech is a biopharmaceuticals company that preserves the integrity of vaccines and other biological materials.

$6.1M raised
Aug 2025

Founder Contacts

30,000+ verified contacts

San Francisco, United States

Terraton is a biochar platform that provides equipment, design, and financing to agribusiness operators.

$11.5M raised
Aug 2025

Founder Contacts

30,000+ verified contacts

Cincinnati, United States

Optimvia is a biopharmaceutical company that specializes in engineering proteins with tailored functions to combat disease.

$523K raised
Aug 2024

Founder Contacts

30,000+ verified contacts

Menlo Park, United States

3T Biosciences is an immunotherapy company that develops next-generation therapies for cancer and immune-mediated diseases.

$40.0M raised
Aug 2022

Founder Contacts

30,000+ verified contacts

Hanover, Germany

Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.

$75.3M raised
Aug 2021

Founder Contacts

30,000+ verified contacts

New York, United States

Ceramedix Holding is a biotherapeutics company that develops antibody-based drugs with the aim of addressing novel diseases.

$3.0M raised
Aug 2023

Founder Contacts

30,000+ verified contacts

Showing 51 to 75 of 854 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 854 biopharma companies tracked in the VCBacked database.

Average Funding
$34.4M
Total Funding Tracked
$859.9M
Countries Represented
6

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.Los Angeles
2 companies$310.0M
2.Cambridge
2 companies$20.0M
3.Singapore
2 companies$2.0M
4.Indianapolis
1 companies$125.0M
5.South San Francisco
1 companies$43.5M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

854 Biopharma Startups (2026) — Recently Funded Companies, Investors & Rounds — Page 3 | VCBacked